PRODUCTS > SUPRALIMUS-CORE
The Supralimus-Core™ Sirolimus ® Stent, Sirolimus
•
Low strut thickness (0.0024''/60µm) without compromise to radiopacity or radial strength.
•
Highly smooth surface results in excellent biocompatibility and hemocompatibility.
•
A cytostatic drug that has potent immunosuppressive and antiproliferative properties.
•
Inhibits expression of key cytokines necessary for the smooth muscle cell proliferation from the G1 to the S phase of the cell cycle.
•
As a part of a DES system, Sirolimus
•
Biodegradable polymers used for coating which remains intact after crimping and post-expansion condition.
•
No Cracking, Webbing, Flaking or De-lamination observed.
•
The drug-polymer coating thickness is 5-6 µm.
Description Supralimus-Core™ Stent
Available Stent Lengths
8, 12, 16, 20, 24, 28, 32, 36, 40 mm
Available Stent Diameters
2.50, 2.75, 3.00, 3.50 mm (6-Crown)
Stent Material
L605 Co-Cr. alloy
Stent Design
Laser cut from seamless tubing in a serpentine pattern
Stent Platform
The CE approved Coronnium® Stent
Stent Strut Thickness
0.06 mm (60µ)
Nominal Stent Foreshortening
< 3%
Recoil
< 4%
Drug
Sirolimus
Polymers Type
Biodegradable Polymers
Infinnium-Core | Supralimus-Core | Supralimus | Coronnium | Infinnium | Matrix
